Apellis Pharmaceuticals sell BiotechBee
Start price
07.09.22
/
50%
€64.19
Target price
31.12.24
€35.00
Performance (%)
8.24%
End price
29.09.22
€69.48
Summary
This prediction ended on 29.09.22 with a price of €69.48. The SELL prediction by BiotechBee shows the price for Apellis Pharmaceuticals slightly increased by 8.24% during the runtime of the prediction. BiotechBee has a follow-up prediction for Apellis Pharmaceuticals, but this time predicts that Apellis Pharmaceuticals is a Buy. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Apellis Pharmaceuticals | - | - | - |
iShares Core DAX® | 2.594% | -1.861% | 13.242% |
iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% |
iShares Nikkei 225® | 0.687% | -8.704% | 17.510% |
iShares S&P 500 | 2.209% | -1.988% | 27.632% |
According to BiotechBee what are the pros and cons of Apellis Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Apellis Pharmaceuticals diskutieren
Sell mit Kursziel 35,0
In the thread Trading Apellis Pharmaceuticals
Sell beendet
Current prediction by BiotechBee for Apellis Pharmaceuticals
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€41.00
17.09.23
17.09.23
€60.00
30.09.25
30.09.25
13.60%
26.04.24
26.04.24
Could be very worthwhile Investment >20% year
Stopped prediction by BiotechBee for Apellis Pharmaceuticals
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€37.00
30.07.23
30.07.23
€50.00
31.01.26
31.01.26
10.81%
17.09.23
17.09.23
Could be very worthwhile Investment >20% year
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€50.50
17.07.23
17.07.23
€90.00
31.03.26
31.03.26
18.81%
17.07.23
17.07.23
Could be very worthwhile Investment >20% year
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€69.48
29.09.22
29.09.22
€80.00
31.12.24
31.12.24
17.30%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year